TED Ted Baker Plc

RNS Number:4115O
Tepnel Life Sciences PLC
21 December 2006




FOR IMMEDIATE RELEASE

 
                 Tepnel Life Sciences plc ('Tepnel' or 'the Company')


 Tepnel signs international distribution agreement with world's largest online
                         supplier of antibodies, Abcam




Manchester, U.K, 21st December 2006 Tepnel Life Sciences PLC (AIM: TED), the
UK-based international Molecular Diagnostics and Research Products & Services
group, announced today that it has signed a global licensing agreement with the
world's largest online supplier of antibody products, Abcam (www.abcam.com) for
the distribution of Tepnel's Diaclone range of diagnostic and research products.
The initial agreement includes an upfront payment to Tepnel and a guaranteed
annual minimum in sales. The move significantly extends Tepnel's reach and will
provide immediate access to a broad range of customers from both academia and
industry.



Dr Allan Brown, Managing Director of Tepnel Research Products & Services
commented, "The agreement with Abcam is a significant one for Tepnel as our
Diaclone product range is already one of the world's leading sources of
immunological products and with our new partnership, we will be able to further
extend our market share.  As the number one player in this market, Abcam
possesses the awareness, reputation and know-how to help attain the market
potential for Diaclone products."



The distribution partnership with Abcam is an exclusive agreement for sales in
Japan, Canada, and South America, co-exclusive (Tepnel and Abcam) in the US, and
non-exclusive elsewhere. Tepnel will continue to sell direct to customers in
France, where the Diaclone division is headquartered.



Established in 1986, the Diaclone division of Tepnel is fully dedicated to the
development of immunological products designed for therapy, diagnostic and
research applications. The vast Diaclone range includes products covering the
fields of cytokines, and cytokine receptors, adhesion, apoptosis and CD
antigens. All Diaclone products are manufactured according to ISO9001:2000
guidelines.





                                     -End-






For Further Information:

Tepnel Life Sciences plc
Allan Brown, Managing Director, Tepnel Research Products & Services
0161 946 2200


De Facto Communications
Richard Anderson
020 7861 3838


Notes to Editors

About Tepnel Life Sciences plc

Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences
products and services group with two main divisions, Molecular Diagnostics and
Research Products & Services. The Company has laboratories, manufacturing and
operations in the USA, UK and France with 195 employees.  TLS provides test
kits, reagents and services to two highly synergistic markets, these being
Molecular Diagnostics and Biomedical Research.  The company's strategy has been
to identify high growth niche opportunities within these multi-billion pound
markets.  TLS focuses on these niche opportunities with internally developed
products, patents, expertise and know-how as well as strategic acquisitions, to
develop a leadership position within these defined market segments.

For further information, please visit: www.tepnel.com.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

AGRTBBLTMMITMJF

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024